Scribble Labs Corp.

Cover Block

PUBLIC

Field	Value
Name	Scribble Labs Corp.
Tagline	AI-powered clinical assistant streamlining real-time documentation for home health clinicians
Headquarters	Malvern, Pennsylvania, United States
Stage	Seed
Business Model	SaaS
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America
Founding Team	Sandeep Banga, Founder and CEO [ZoomInfo]

Links

PUBLIC

• Website: https://goscribble.ai/
• YouTube: https://www.youtube.com/@ScribbleLabsAI
• Instagram: https://www.instagram.com/scribble__labs/

Executive Summary

PUBLIC

Scribble Labs Corp. is a Malvern, Pennsylvania healthtech company building an ambient AI clinical assistant aimed squarely at the home health segment, a corner of U.S. healthcare where documentation burden is acute and where the larger AI scribe vendors have not yet concentrated their go-to-market. The product activates with a single tap on a clinician's device and runs in the background during a patient visit, generating documentation so that clinicians can spend more time on care delivery and less on paperwork [goscribble.ai]. The company positions itself explicitly around the cost constraints of home health agencies, with a pricing model the company says is tailored to that buyer [goscribble.ai]. Founder and CEO Sandeep Banga is listed in third-party records with prior experience that includes a leadership role at LinkedIn [ZoomInfo]. Public financial disclosure is thin: ZoomInfo reports revenue under $5 million and no priced funding rounds have surfaced in the captured sources [ZoomInfo]. Over the next 12 to 18 months the questions that will determine whether Scribble graduates from a focused seed-stage tool into a defensible category player are whether it can sign and publicize home health agency customers, whether it can articulate a defensible differentiation against the much larger ambient scribe vendors moving down-market, and whether it can attach a named institutional investor to a priced round.

Data Accuracy: YELLOW -- Founder and revenue band confirmed via ZoomInfo; product claims confirmed via the company website; no independent press coverage of funding or customers surfaced.

Taxonomy Snapshot

Axis	Value
Stage	Seed
Business Model	SaaS
Industry / Vertical	Healthtech, home health documentation
Technology Type	AI / Machine Learning, ambient voice
Geography	North America

Company Overview

PUBLIC

Scribble Labs Corp. operates out of Malvern, Pennsylvania and markets its product under the goscribble.ai domain. The company describes itself in plain terms on its About page: it exists so that clinicians can focus on "patients, not paperwork," and it has built its commercial model around the budget realities of home health agencies rather than large hospital systems [goscribble.ai]. The choice of segment is itself a statement of strategy. Home health is a fragmented, regulation-heavy market in which clinicians document in patient homes, often offline, often on tablets, and where the established hospital-grade ambient scribe vendors have historically concentrated their efforts on inpatient and ambulatory specialty workflows.

Third-party records identify Sandeep Banga as Founder and Chief Executive Officer, with prior experience that includes a leadership role at LinkedIn before founding Scribble Labs [ZoomInfo]. The company maintains a presence on YouTube and Instagram under the Scribble Labs brand, which suggests a consumer-style content motion alongside the direct-to-agency sales effort. A founding year is not disclosed in the captured sources, and no priced funding round, lead investor, or accelerator affiliation has been independently reported. Several unrelated companies share variants of the Scribble name, including Scribble AI (a consumer blog writing tool) and Scribbl (a meeting notes product) [Scribbleai.com; LinkedIn]; this report concerns only Scribble Labs Corp. of Malvern, Pennsylvania.

Data Accuracy: YELLOW -- HQ, founder, and product positioning corroborated by ZoomInfo and the company website; founding year and entity history are not publicly available.

Product and Technology

MIXED

The product is an ambient AI clinical assistant designed for the home visit. According to the company, a clinician begins a visit and activates Scribble on their device with a single tap, after which the AI "is ready to go, working silently in the background" [PUBLIC] [goscribble.ai]. The implied workflow is consistent with the broader ambient scribe category: the assistant captures the clinician-patient conversation, structures it, and produces draft documentation that the clinician reviews rather than types from scratch. ZoomInfo's third-party summary describes the offering as "an AI-powered clinical assistant designed to enhance patient care by streamlining real-time documentation for home health clinicians" [PUBLIC] [ZoomInfo].

Two product choices stand out. The first is the device-and-tap activation model, which is meaningful in the home health context where clinicians work on tablets in patients' homes and connectivity is variable. The second is pricing. The About page states the company has "designed our pricing model to fit" the cost constraints of home health agencies [PUBLIC] [goscribble.ai]. That is a deliberate positioning decision against the per-clinician pricing common among hospital-focused ambient scribe vendors, where seat costs in the high hundreds to low thousands of dollars per clinician per month would be difficult to absorb in a home health agency's economics. The actual price points, contract structure, and EHR integration partners are not disclosed in the captured sources.

No public information confirms the underlying model stack, whether speech recognition is built in-house or licensed, or which home health electronic record systems Scribble integrates with. Those details would normally surface in job postings or partnership press releases, neither of which were found in this research pass.

Data Accuracy: YELLOW -- Product behavior and pricing posture confirmed by the company website and a ZoomInfo summary; technical architecture and integration partners are not publicly available.

Market Research and Opportunity

PUBLIC

The market that matters here is the intersection of two large and growing pools: U.S. home health services and clinical AI documentation. Both are expanding for structural reasons, and the overlap is the segment Scribble Labs has chosen to serve.

U.S. home health is being pulled forward by demographics and by payer preference for care delivered outside the hospital. The Centers for Medicare and Medicaid Services has consistently identified home health as one of the faster-growing components of national health expenditure, driven by an aging Medicare population and by Medicare Advantage plans steering members toward in-home care to manage cost. Documentation burden in this segment is well documented in clinician surveys and is a meaningful contributor to home health nurse turnover, which agencies have publicly identified as their primary operational constraint. Those are the demand drivers a home-health-specific scribe is positioned to address.

The ambient AI scribe category itself has matured rapidly. Large hospital systems have signed multi-year deployments with vendors such as Abridge, Suki, and Microsoft's Nuance DAX, and venture funding into the category has been substantial across 2023 and 2024 according to broad press coverage of those rounds. The relevant question for Scribble is not whether ambient scribes work (the category has crossed that bar with hospital-grade evidence) but whether home health, with its different workflows, device profile, connectivity profile, and economics, is best served by a hospital-built tool stretched downward or by a purpose-built tool such as Scribble's. The captured research does not include a named third-party report sizing the home-health-specific AI documentation segment, so any TAM figure here would be speculative and is omitted.

Regulation cuts both ways. Home health agencies operate under Medicare Conditions of Participation that mandate detailed visit documentation within tight time windows, which raises the value of any tool that compresses charting time. The same regulatory environment, plus HIPAA, raises the bar for any AI vendor handling protected health information at the point of care, particularly when audio is captured in a patient's home where third parties may be present.

Sizing claim	Value	Source
Scribble Labs reported revenue band	<$5M	[ZoomInfo]

The single hard number available is the ZoomInfo revenue band, which is consistent with a seed-stage company in the early customer phase rather than a scaled commercial entity.

Data Accuracy: ORANGE -- Demand drivers are general industry knowledge widely covered in trade press but not cited to a specific named report in this research pass; only the ZoomInfo revenue band is independently sourced.

Competitive Landscape

MIXED

Scribble Labs is positioned as a vertical, home-health-specific entrant in a category where the largest competitors are horizontal and hospital-first.

The competitive map has three layers. The first layer is the well-funded ambient scribe incumbents that have built their businesses around hospital and large medical group deployments. Press coverage across 2023 and 2024 documents substantial venture rounds and high-profile health system contracts for Abridge, Suki, and Microsoft's Nuance DAX, among others.

The second layer is the home health software stack itself: the EHR vendors that home health agencies already pay, including names such as WellSky, Homecare Homebase, Axxess, and MatrixCare, all of which have either announced or are likely to announce AI documentation features inside their existing products. This is the most strategically important competitive layer for Scribble, because the EHR vendors own the workflow and the data, and bolt-on AI features inside an incumbent system carry a powerful default-choice advantage even if the standalone tool is technically inferior.

The third layer is brand confusion. Several unrelated software products operate under similar names, including Scribble AI, a consumer blog writing tool [Scribbleai.com], and Scribbl, a meeting notes product co-founded by John Coschigano [LinkedIn]. None of these are clinical products and none compete for the same buyer, but the naming overlap is a real go-to-market friction point that will surface in search, in conference recall, and in inbound demand qualification.

Where Scribble has a defensible edge today, the edge is segment focus rather than technology. A product purpose-built for home visits, on tablets, with offline-tolerant capture and a price point sized for an agency rather than an academic medical center, is a meaningfully different product than a hospital scribe in trial mode. That edge is durable for as long as the larger horizontal vendors continue to prioritize the much larger hospital revenue pools, and perishable the moment one of them, or one of the home health EHR incumbents, ships a credible home-health-specific module. The most plausible 18-month scenario: Scribble wins if it can publish two or three named home health agency customers with hard productivity data before a major EHR vendor ships an embedded ambient scribe; Scribble loses ground if WellSky, Homecare Homebase, or Axxess announces a native ambient documentation feature included in existing seat licenses, because that effectively zeroes the marginal cost of the incumbent option.

Data Accuracy: ORANGE -- Category structure is widely covered in healthtech trade press; no head-to-head competitor comparison was surfaced in the captured sources for Scribble Labs specifically.

Opportunity

PUBLIC

If Scribble Labs executes against the home health segment with discipline, the prize is to become the default ambient documentation layer for an entire underserved corner of U.S. healthcare.

The headline opportunity. Home health is one of the few large clinical segments where the dominant ambient AI scribes have not yet concentrated their effort, and where the existing EHR incumbents have historically been slow to ship modern AI-native features. A focused vertical entrant that arrives first with a product calibrated to the home visit workflow and the agency's price point can plausibly become the standard tool for thousands of agencies, in the same pattern by which vertical SaaS companies have repeatedly captured fragmented, underserved professional segments. The cited evidence supports the segment choice: the product is explicitly designed for the home visit (single-tap activation, background operation) [goscribble.ai] and the pricing is explicitly designed for the home health agency cost structure [goscribble.ai]. Those are not generic claims; they are specific product decisions consistent with a vertical strategy.

Growth scenarios.

Scenario	What happens	Catalyst	Why it's plausible
Vertical default	Scribble becomes the de facto ambient scribe for mid-market home health agencies before horizontal incumbents prioritize the segment	Two or three reference agency deployments with measurable visit-time savings	Product is purpose-built for the home visit workflow [goscribble.ai]
EHR partnership	Scribble is embedded as the AI documentation layer inside one of the major home health EHRs rather than competing with it	A distribution agreement with a WellSky, Axxess, or Homecare Homebase tier vendor	Home health EHRs face customer pressure to add AI features and partnering is faster than building
Payer-led adoption	A Medicare Advantage plan or large home health network mandates ambient documentation across its provider base for quality reporting	Regulatory or payer quality requirement that rewards structured visit documentation	CMS Conditions of Participation already mandate detailed visit notes within tight windows

What compounding looks like. The flywheel in vertical clinical AI is data-driven and reference-driven. Each agency deployment generates home-visit-specific audio and documentation patterns that improve the model for the next agency, while every published productivity result (minutes saved per visit, charting completion rates, nurse retention impact) lowers the cost of the next sale. Distribution compounds separately: home health is a community where regional agency operators talk to each other, and reference selling in this segment historically converts faster than cold outbound. The captured sources do not yet document a named customer or a published productivity result, so the flywheel is a thesis rather than an observed fact at this stage.

The size of the win. A credible upside comparable is the valuation trajectory of the horizontal ambient scribe leaders, which press coverage across 2024 has placed in the multi-billion-dollar range on the strength of hospital contracts. A vertical winner in home health would not reach those numbers on hospital-style ACVs, but the segment is large enough, and the per-clinician documentation problem severe enough, that a category-defining home health scribe could plausibly support a valuation in the high hundreds of millions to low billions if it captures meaningful share (scenario, not a forecast). The path requires demonstrated agency adoption, defensible integration with the home health EHR stack, and a credible answer to the inevitable moment when a horizontal incumbent decides home health is worth a focused effort.

Data Accuracy: ORANGE -- Scenarios are analytically constructed from the cited product positioning and from widely reported category dynamics; no named customer, partnership, or priced funding round is publicly confirmed for Scribble Labs at this time.

Sources

PUBLIC

1. [goscribble.ai] Home - Scribble | https://goscribble.ai/

2. [goscribble.ai] Patients, Not Paperwork - Scribble (About Us) | https://goscribble.ai/about-us/

3. [ZoomInfo] Scribble Labs - Overview, News & Similar companies | https://www.zoominfo.com/c/scribble-labs-corp/1339879087

4. [ZoomInfo] Sandeep Banga, Founder & Chief Executive Officer at Scribble Labs | https://www.zoominfo.com/p/Sandeep-Banga/1347536031

5. [ZoomInfo] Scribble Labs: Employee Directory | https://www.zoominfo.com/pic/scribble-labs-corp/1339879087

6. [YouTube] Scribble Labs channel | https://www.youtube.com/@ScribbleLabsAI

7. [Instagram] Scribble Labs (@scribble__labs) | https://www.instagram.com/scribble__labs/

8. [Scribbleai.com] Scribble - Your AI Blog Writing Expert (unrelated company, cited for naming-confusion context) | https://www.scribbleai.com/

9. [LinkedIn] John Coschigano, Co-founder at Scribbl (unrelated company, cited for naming-confusion context) | https://www.linkedin.com/in/johncosch/